Reckitt Benckiser pays $1.4 billion in opioid settlement | KOB 4
Advertisement

Reckitt Benckiser pays $1.4 billion in opioid settlement

July 11, 2019 10:21 AM

LONDON (AP) — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

Advertisement

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Credits

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Comment on Facebook

Share 4 - News Tips - Photos - Videos
  Share a News Tip, Story Idea, Photo, Video



Advertisement


Advertisement

Advertisement


New Mexico sizes up potential of recreational pot market

Takeaways from 1st day of House public impeachment hearings

Justice Dept. rolls out new program to combat gun violence

Texas man arrested after teen daughter found dead in Rio Grande

APD: 17-year-old killed in apparent accidental shooting